{"id":59065,"date":"2024-03-19T16:04:47","date_gmt":"2024-03-19T15:04:47","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/"},"modified":"2024-03-19T16:04:47","modified_gmt":"2024-03-19T15:04:47","slug":"almaden-genomics-and-elucidata-pair-g-nome-with-polly","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/","title":{"rendered":"Almaden Genomics and Elucidata Pair g.nome\u00ae with Polly"},"content":{"rendered":"
\n

DALLAS–(BUSINESS WIRE)–Almaden Genomics has partnered with Elucidata to incorporate Polly\u2019s data harmonization engine into g.nome\u00ae, significantly expanding the number of datasets available in the cloud-native omics data science solution. Now equipped to deliver greater insights with Polly\u2019s comprehensive collection of harmonized biomolecular data, g.nome becomes an even more complete end-to-end offering for researchers.<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cPolly will live at the frontend of g.nome, enabling an easy transition into secondary analysis,\u201d said David Gascogine, Chief Executive Officer of Almaden Genomics. \u201cPartnerships like this help us populate the complete analysis pipeline in g.nome, which gives researchers an easy starting point, allowing them to explore their data and get to insights faster.\u201d<\/p>\n

\nAiming to adopt an integrated approach with access to ML-ready data, Polly harmonizes the vast and diverse biological data from in-house experiments, public repositories, CROs, and clinical trials.<\/p>\n

\n\u201cWhen we find ways to make the data we have do more, we have the chance to truly accelerate discovery,\u201d said Abhishek Jha, co-founder and CEO of Elucidata. \u201cWe are helping life sciences companies harmonize data that is traditionally scattered across multiple, disparate sources but holds tremendous potential for reuse and drug discovery. Through our partnership with g.nome, any scientist can now do something useful with their data.\u201d<\/p>\n

\ng.nome delivers pre-built, transparent, and fully modifiable workflows that enable researchers to unlock results quickly and easily, and to dig deeper where needed\u2014with a complete understanding of the results and where they came from.<\/p>\n

\nAbout Elucidata<\/b><\/p>\n

\nElucidata<\/a> was founded in 2015 with the mission to give back every possible hour spent on routine data and MLops tasks to scientists, shifting their focus to high-value research, and eventually ensuring that drugs reach patients sooner. Elucidata provides solutions for R&D teams to better leverage data and reduce their drug development timelines. Polly’s powerful harmonization engine processes data from experiments, CROs and public repositories, links them to harmonized metadata and transforms them into ML-ready formats. Elucidata has offices in San Francisco, Cambridge(MA), New Delhi, and Bangalore.<\/p>\n

\nAbout Almaden Genomics<\/b><\/p>\n

\nAlmaden Genomics provides the power of simplified data exploration and rapid iteration to enable a higher probability of success in drug discovery. With Almaden\u2019s g.nome\u00ae data analysis solution, scientists have an end-to-end approach to discovery with complete visibility, traceability and reproducibility of the results. The cloud-based platform integrates quickly and easily to immediately impact research goals by providing an intuitive interface that encourages effortless iteration and collaboration. Almaden Genomics is a Catalyze Partners (www.catalyze.partners<\/a>) portfolio company. For more information, visit www.almaden.io<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nMichele Hodde
\n
michele.hodde@catalyze.partners<\/a>
303-304-7161<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

DALLAS–(BUSINESS WIRE)–Almaden Genomics has partnered with Elucidata to incorporate Polly\u2019s data harmonization engine into g.nome\u00ae, significantly expanding the number of datasets available in the cloud-native omics data science solution. Now equipped to deliver greater insights with Polly\u2019s comprehensive collection of harmonized biomolecular data, g.nome becomes an even more complete end-to-end offering for researchers. \u201cPolly will … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59065","6":"format-standard","7":"category-industry"},"yoast_head":"\nAlmaden Genomics and Elucidata Pair g.nome\u00ae with Polly - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Almaden Genomics and Elucidata Pair g.nome\u00ae with Polly - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DALLAS–(BUSINESS WIRE)–Almaden Genomics has partnered with Elucidata to incorporate Polly\u2019s data harmonization engine into g.nome\u00ae, significantly expanding the number of datasets available in the cloud-native omics data science solution. Now equipped to deliver greater insights with Polly\u2019s comprehensive collection of harmonized biomolecular data, g.nome becomes an even more complete end-to-end offering for researchers. \u201cPolly will ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-19T15:04:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240319282176\/en\/2071755\/22\/AlmadenLogo_V_Transparent.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Almaden Genomics and Elucidata Pair g.nome\u00ae with Polly\",\"datePublished\":\"2024-03-19T15:04:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\\\/\"},\"wordCount\":448,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240319282176\\\/en\\\/2071755\\\/22\\\/AlmadenLogo_V_Transparent.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\\\/\",\"name\":\"Almaden Genomics and Elucidata Pair g.nome\u00ae with Polly - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240319282176\\\/en\\\/2071755\\\/22\\\/AlmadenLogo_V_Transparent.jpg\",\"datePublished\":\"2024-03-19T15:04:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240319282176\\\/en\\\/2071755\\\/22\\\/AlmadenLogo_V_Transparent.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240319282176\\\/en\\\/2071755\\\/22\\\/AlmadenLogo_V_Transparent.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Almaden Genomics and Elucidata Pair g.nome\u00ae with Polly\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Almaden Genomics and Elucidata Pair g.nome\u00ae with Polly - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/","og_locale":"en_US","og_type":"article","og_title":"Almaden Genomics and Elucidata Pair g.nome\u00ae with Polly - Pharma Trend","og_description":"DALLAS–(BUSINESS WIRE)–Almaden Genomics has partnered with Elucidata to incorporate Polly\u2019s data harmonization engine into g.nome\u00ae, significantly expanding the number of datasets available in the cloud-native omics data science solution. Now equipped to deliver greater insights with Polly\u2019s comprehensive collection of harmonized biomolecular data, g.nome becomes an even more complete end-to-end offering for researchers. \u201cPolly will ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/","og_site_name":"Pharma Trend","article_published_time":"2024-03-19T15:04:47+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240319282176\/en\/2071755\/22\/AlmadenLogo_V_Transparent.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Almaden Genomics and Elucidata Pair g.nome\u00ae with Polly","datePublished":"2024-03-19T15:04:47+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/"},"wordCount":448,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240319282176\/en\/2071755\/22\/AlmadenLogo_V_Transparent.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/","url":"https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/","name":"Almaden Genomics and Elucidata Pair g.nome\u00ae with Polly - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240319282176\/en\/2071755\/22\/AlmadenLogo_V_Transparent.jpg","datePublished":"2024-03-19T15:04:47+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240319282176\/en\/2071755\/22\/AlmadenLogo_V_Transparent.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240319282176\/en\/2071755\/22\/AlmadenLogo_V_Transparent.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/almaden-genomics-and-elucidata-pair-g-nome-with-polly\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Almaden Genomics and Elucidata Pair g.nome\u00ae with Polly"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59065","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59065"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59065\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59065"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59065"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59065"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}